SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
SEC Accession No. 0000950123-15-002090
Filing Date
2015-02-13
Accepted
2015-02-13 16:29:40
Documents
2
Period of Report
2014-12-31
Effectiveness Date
2015-02-13

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-HR  
1 primary_doc.xml 13F-HR 2021
2 INFORMATION TABLE FOR FORM 13F form13fInfoTable.html INFORMATION TABLE  
2 INFORMATION TABLE FOR FORM 13F form13fInfoTable.xml INFORMATION TABLE 51887
  Complete submission text file 0000950123-15-002090.txt   55109
Mailing Address FREISCHUETZGASSE 3 ZURICH V8 8004
Business Address FREISCHUETZGASSE 3 ZURICH V8 8004 41-61-275-9200
Adamant Biomedical Investments AG (Filer) CIK: 0001542336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 13F-HR | Act: 34 | File No.: 028-14829 | Film No.: 15615141